thalidomide has been researched along with Anemia, Leukoerythroblastic in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tefferi, A | 1 |
| Cortes, J | 1 |
| Verstovsek, S | 1 |
| Mesa, RA | 1 |
| Thomas, D | 1 |
| Lasho, TL | 1 |
| Hogan, WJ | 1 |
| Litzow, MR | 1 |
| Allred, JB | 1 |
| Jones, D | 1 |
| Byrne, C | 1 |
| Zeldis, JB | 1 |
| Ketterling, RP | 1 |
| McClure, RF | 1 |
| Giles, F | 1 |
| Kantarjian, HM | 1 |
1 trial available for thalidomide and Anemia, Leukoerythroblastic
| Article | Year |
|---|---|
Lenalidomide therapy in myelofibrosis with myeloid metaplasia.
Topics: Administration, Oral; Adult; Aged; Anemia; Anemia, Myelophthisic; Female; Hemoglobins; Humans; Janus | 2006 |